Ars Pharmaceuticals Inc (SPRY)
Total Liabilities
$236.98M
Quarterly · Period ending: · USD
SPRY Total Liabilities
Latest reported$236.98Mperiod ending
Latest reported$236.98Mperiod ending
SPRY Quarterly Total Liabilities ($21.25M → $236.98M)
Quarterly total liabilities
High-resolution chart · PNG
SPRY total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 236,983,000 | |
| 226,263,000 | |
| 213,394,000 | |
| 225,148,000 | |
| 121,151,000 | |
| 98,344,000 | |
| 94,355,000 | |
| 16,623,000 | |
| 6,725,000 | |
| 3,715,000 | |
| 2,428,000 | |
| 11,272,000 | |
| 10,200,000 | |
| 10,037,000 | |
| 8,549,000 | |
| 13,848,000 | |
| 90,081,000 | |
| 19,239,000 | |
| 92,715,000 | |
| 20,427,000 | |
| 17,326,000 | |
| 13,650,000 | |
| 11,927,000 | |
| 21,250,000 |